Alfresa Holdings Corporation (ALFRY)
OTCMKTS · Delayed Price · Currency is USD
15.99
0.00 (0.00%)
May 27, 2025, 4:00 PM EDT

Alfresa Holdings Company Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.

It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies.

The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.

In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals.

Further, the company’s medical-related business includes its dispensing pharmacy and other medical-related businesses.

The company was incorporated in 2003 and is based in Tokyo, Japan.

Alfresa Holdings Corporation
Country Japan
Founded 2003
Industry Medical Distribution
Sector Healthcare
Employees 12,517
CEO Ryuji Arakawa

Contact Details

Address:
1-1-3 Otemachi
Tokyo, 100-0004
Japan
Phone 81 3 5219 5100
Website alfresa.com

Stock Details

Ticker Symbol ALFRY
Exchange OTCMKTS
Fiscal Year April - March
Reporting Currency JPY
ISIN Number US0155091020
SIC Code 5122

Key Executives

Name Position
Ryuji Arakawa President and Representative Director
Seiichi Kishida Deputy President of General Affairs, Fin Planning, Corp Comm., Compliance and Risk Mgmt. and Director
Yusuke Fukujin Deputy President and Director
Shigeki Ohashi Vice President and Executive Officer
Toshiki Tanaka Vice President and Executive Officer
Kazuaki Hano Executive Officer
Soichi Nemoto Executive Officer
Toshikazu Urakabe Executive Officer
Takashi Sasaki Executive Officer